Pancreatic b cell dysfunction and loss of b-cell mass are the major mechanisms contributing to insulin insufficiency in type 2 diabetes, but whether the two mechanisms are linked at the molecular level is still unclear. Rane and colleagues now show that cyclindependent kinase 2 (Cdk2) couples these events in diabetes (JBC (2017) doi: 10.1074/jbc.M116.754077).
The authors generated pancreas-specific Cdk2 knockout mice (Cdk2-pKO) to investigate the role of Cdk2, as genome-wide association studies have previously identified enriched cell cycle loci in patients with type 2 diabetes. Cdk2-pKO mice became glucose-intolerant at the age of 2 months as a result of defects in glucose-stimulated insulin secretion. b cells of Cdk2-pKO mice had defective mitochondrial morphology and impaired metabolic response to glucose. Loss of Cdk2 also decreased glucose-dependent phosphorylation and inactivated the transcription factor FoxO1, further supporting a role for Cdk2 in b-cell function. Cdk2-pKO mice became more glucoseintolerant with age or overnutrition, and showed progressive loss of b-cell mass due to decreased b-cell proliferation. Thus, b-cell dysfunction and loss of bcell mass in diabetes are coupled via a Cdk2-dependent mechanism, suggesting that Cdk2 agonists might be useful therapeutics to counter b-cell dysfunction and loss in type 2 diabetes.
Quantitative proteomics identify key proteins in cancer invasiveness
Cancer cell invasion takes place as ductal carcinoma in situ (DCIS) progresses into invasive ductal carcinoma (IDC) following loss of cell polarity, but the molecular machinery involved has not been completely identified. Previous studies suggest that the Rab17 GTPase may counteract DCIS to IDC transition and Norman, Zanivan and colleagues now reveal how Rab17 mediates its anti-invasive effects (J. Cell Sci. Using a quantitative SILAC-based global proteomic analysis, the authors identified the v-SNARE protein Vamp8 as significantly downregulated in Rab17-knockdown MDA-MB-231 breast cancer cells relative to control cells. siRNA-mediated silencing of either Rab17 or Vamp8 altered the symmetrical distribution and increased the invasiveness of MDA-MB-231 cells when cultured in 3D Matrigel, recapitulating the DCIS to IDC transition and supporting a Vamp8-dependent anti-invasive role for Rab17.
Using affinity-based proteomic fractionation and mass spectrometry, the authors quantified proteins present at the cell surface or within endosomes in Rab17-knockdown and control cells. Rab17 depletion increased cell surface expression and decreased endosomal localisation of neuropilin-2 (NRP2), a protein that has previously been linked to invasion and migration. Live-cell fluorescence imaging confirmed a role for Rab17-and Vamp8-dependent NRP2 trafficking in mediating invasiveness. Indeed, silencing of NRP2 counteracted the ability of Rab17 or Vamp8 knockdown to drive invasiveness in 3D-cultured MDA-MB-231 cells.
TORC2 signalling modulates Akl1 to regulate endocytosis
The activity of the target of rapamycin (TOR) complex 2 (TORC2) in Saccharomyces cerevisiae is regulated in part by plasma membrane composition and tension and membrane stresses induce TORC2-mediated phosphorylation of the downstream kinase Ypk1, which in turn phosphorylates and inactivates the kinase Fpk1. A role for Fpk1 in actin organisation and endocytosis has been proposed; however, the relevant substrates were unknown. Thorner and colleagues now reveal that Fpk1 phosphorylates and negatively regulates Akl1 to modulate endocytosis (Mol. Cell. Biol. (2016 ) doi: 10.1128 .
After identifying two potential Fpk1 phospho-acceptor site motifs in the C terminus of Akl1, the authors confirmed that Fpk1 phosphorylates Ser 960 and Ser 1027 in vitro and in vivo upon inhibition of TORC2. An Akl1 mutant lacking its Fpk1 sites displayed enhanced kinase activity, suggesting that Fpk1-mediated phosphorylation inhibits Akl1 activity. Given that Akl1 had been implicated in endocytosis, the authors examined whether Fpk1-dependent Akl1 phosphorylation might regulate this process, and found that cells expressing the phospho-site-deficient Akl1 showed decreased endocytic uptake. Thus, activation of TORC2 would be expected to inhibit endocytosis via this pathway, potentially facilitating recovery from membrane stress. 
